- Record: found
- Abstract: not found
- Article: not found
A chemogenomic screening identifies CK2 as a target for pro-senescence therapy in PTEN-deficient tumours
Read this article at
ScienceOpenPubMed
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.